Oxidized Lipids in Atherogenesis: Formation, Destruction and Action

• References

• 1 Parthasarathy S, and Rankin SM. The role of oxidized LDL in atherogenesis. Prog Lipid Res 31: 127-143 1992;
• 2 Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792 1991;
• 3 Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816 1993;
• 4 Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, and Steinberg D. The 94 to 97 KD mouse macrophage membrane protein that recognizes oxidized LDL and phosphatidylserine rich liposomes is identical to macrosialin, the mouse homologue of CD68. Proc Natl Acad Sci US 92: 9580-9584 1995;
• 5 Hughes H, Matthews B, Lenz ML, and Guyton JR. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7 ketochol7esterol and 7-hydroxycholesterol. Arterioscler. Thromb 14: 1177-1184 1994;
• 6 Colles SM, Irwin KC, and Chisolm GM. Role of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. J Lipid Res 37: 2018-2028 1996;
• 7 Reid VC, Mitchinson MJ. Toxicity of oxidized LDL towards mouse peritoneal macrophages in vitro. Atherosclerosis 98: 17-24 1993;
• 8 Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, and Lusis AJ. Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation and Genetics. Circulation 91: 2488-2496 1995;
• 9 Berliner JA, and Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radicals in Biol and Med 20: 707-727 1996;
• 10 Weis JR, Pitas RE, Wilson BD, Rod gers. Oxidized LDL increases cultured human endothelial cell tissue factor activity and reduces protein C activation. G M Faseb J 05: 2459-2465 1991;
• 11 Drake TA, Hannani K, Fei H, Lavi S, and Berliner JA. MM-LDL induces tissue factor expression in cultured human endothelial cells. Am J Pathol 138: 601-607
• 12 Brand L, Banka CL, Madmann TerkillaubPA, Faust CurtissLK. Oxidized LDL entrance LPS induced tissue factor expression in adherent monocytes, Arterioscler. Thromb 14: 790-797 1994;
• 13 Tipping PG, Davenport P, Gallicchio M, Filonzi EL, Apostolopoulos J, and Wojta J. Atheromatous plaque macrophages produce PAI-1 and stimulate its production by endothelial cells and smooth muscle cells. Am J Path 143: 875-885 1993;
• 14 Murugesan G, Chisolm GM, Fox PL. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol 120: 1011-1019 1993;
• 15 Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, La DuBN, Fogelman AM, and Berliner JA. Effect of Platelet Activating Factor-Acetylhydrolase on the Formation and action of minimally oxidized LDL. J Clin Invest 95: 774-782 1995;
• 16 Watson AD, Berliner JA, Hama SY, La DuBN, Faull KF, Fogelman AM, and Navab M. Protective effect of HDL associated paraoxonase-inhibition of the biological activity of minimally oxidized LDL. J Clin Invest 95: 2882-2891 1995;
• 17 Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, and Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized LDL that induce monocyte/endothelial interactions and evidence fro their presence in vivo. J Biol Chem. In Press
• 18 Liao F, Andalibi A, deBeer F, Fogelman AM, and Lusis AJ. Genetic control of inflammatory gene induction and nf-kB like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91: 2572-2579 1993;
• 19 Liao F, Andaibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction and aortic fatty streak formation in mice. J Clin Invest 94: 877-884 1994;
• 20 Ohara Y, Petersen TE, and Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546-2551 1993;
• 21 Van LentenB J, Prieve J, Navah M, Hama S, Lusis AJ, Fogelman AM. Lipid-induced changes in intracellular iron homeostasisin vitroandin vivo. . J Clin Invest 95: 2104-2110 1995;
• 22 Lynch SM, and Frei B. Antioxidants as Anti-Atherogens: Animal Studies. In “Natural Antioxidants in Human Health & Disease”. Ed Frei B. Academic Press; Orlando, FL: 1994
• 23 Palinski W, Miller E, and Witztum JL. Immunization of LDL receptor deficient rabbits with homologous MDA-LDL reduces atherogenesis.Proc. Natl Acad Sci 92: 821-825 1995;
• 24 Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van LentenBJ, Frank JS, Demer LL, Edwards PA, and Fogelman AM. The Yin and Yang of oxidation in the development of the fatty streak. Arteroscler. Thromb Vase Biol 16: 831-842 1996;
• 25 Stafforini DM, immerman GA, McIntyre TM, Prescott SM. The platelt activating factor acetylhydrolase from human plasma prevents oxidative modification of LDL. Trans Assoc Am Physicians 105: 44-63 1993;
• 26 Mackness MI, Arrol D, durrington P. Paraoxonase prevents accumulation of lipoperoxides in LDL. FEBS Lett 286: 152-154 1991;
• 27 Dentan C, Lesnik M, Chapman J, Ninjo E. PAF acether degrading acetylhydrolase in plasma is inactivated by copper and cell mediated oxidation. Arterioscer. Thromb 14: 353-360 1994;
• 28 Ameli SA, Hltgardh-Nillson A, Regnstrom J, Caldara F, Yano J, Cercek B, Shah PK, and Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb Vase Biol 16: 1074-1079 1996;
• 29 Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, and Berliner JA. Minimally modified LDL induced inflammatory responses in endothelial cells are mediated by cyclic adensosine monophosphate. J Clin Invest 92: 471-478 1993;
• 30 Khan BV, Parthasarathy S, Alexander RW, and Medford RM. Modified LDL and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95: 1262-1270 1995;
• 31 Rajavashisth TB, Yamada H, and Mishra NK. Transcriptional activation of the MCSF gene by minimally modified LDL: Involvement of NFkB. Arterioscler. Thromb Vase Biol 15: 1591-1598 1995;
• 32 Uyemura K, Demer LL, Castle SC, Julien D, Berliner JA, Gately MK, Warner RR, Phain N, Fogelman AM, and Modlin Rl. Cross Regulatory Roles of IL-12 and IL-10 in atherosclerosis. J Clin Invest 97: 2130-2138 1996;
• 33 Johansson J, Olsson AG, Bergstrand L, Elinder LS, Nilsson S, Erikson U, Molgaard J, Holme I, and Walldius G. Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A PQRST Report. Arterioscler Thromb Vase Biol 15: 1049-1056 1995;
• 34 Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, and Mitchinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease. CHAOS study. Lancet 347: 781-786 1996;